The global radiopharmaceutical market is poised for substantial growth, driven by significant healthcare expenditures and scientific innovations in affluent economies. According to a recent report by Future Market Insights (FMI), the market is expected to achieve a valuation of USD 6972.1 million by 2024. Increasing awareness of the benefits of radioisotope medications is a key factor …
Tag Archives: Radiopharmaceuticals Market
Global Radiopharmaceuticals Market Continues Upward Trajectory, Projected to Reach US$ 11635 Million by 2034, at a 3.40% CAGR
The global radiopharmaceutical market would be worth US$6972.1 million by 2024. This valuation is expected to surpass US$ 11635 million by 2034 due to growing awareness of the advantages of radioisotope treatments. The Compound Annual Growth Rate (CAGR) for the forecast period of 2024 to 2034 is estimated to be 3.40%. Radiopharmaceuticals are unique medications that utilize …
Radiopharmaceuticals Market Targets US$ 9.5 Billion Milestone by 2032, Accelerating Growth in Nuclear Medicine
The Radiopharmaceuticals Market has experienced substantial growth in recent years, driven by the increasing adoption of nuclear medicine procedures, advancements in molecular imaging technologies, and a growing prevalence of chronic diseases. Radiopharmaceuticals are radioactive compounds used in nuclear medicine imaging and targeted therapy to diagnose and treat various medical conditions, including cancer, cardiovascular diseases, and neurological disorders. …
Radiopharmaceuticals Market Aims for US$ 9.5 Billion Milestone by 2032-FMI Projection
The Radiopharmaceuticals Market has experienced substantial growth in recent years, driven by the increasing adoption of nuclear medicine procedures, advancements in molecular imaging technologies, and a growing prevalence of chronic diseases. Radiopharmaceuticals are radioactive compounds used in nuclear medicine imaging and targeted therapy to diagnose and treat various medical conditions, including cancer, cardiovascular diseases, and neurological disorders. …
Radiopharmaceuticals Market is anticipated to value CAGR of 4.3% by 2032
As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market registered steady year-on-year growth Future Market Insights (FMI) predicted that the market for radiopharmaceuticals would be valued US$ 6.2 billion in 2022. The market for radiopharmaceuticals is expected to grow at a value CAGR of 4.3% between 2022 and …
Continue reading “Radiopharmaceuticals Market is anticipated to value CAGR of 4.3% by 2032”
Radiopharmaceuticals Market is anticipated to value CAGR of 4.3% to reach US$ 9.5 Billion 2022 to 2032
Future Market Insights predicts that shorter half-life of radiopharmaceuticals, and lack of specified guidelines for their use in commercial-scale drug production will restrict the market from growing at higher rate. In the years to come, ageing research reactors from all corners of the world will be closed, which will significantly bring down global production of radiopharmaceuticals. …
Radiopharmaceuticals Market is anticipated to US$ 9.5 Billion by 2022 to 2032
Future Market Insights (FMI) predicted that the market for radiopharmaceuticals would be valued US$ 6.2 billion in 2022. The market for radiopharmaceuticals is expected to grow at a value CAGR of 4.3% between 2022 and 2032, reaching US$ 9.5 billion. North America will account for more than 47% of the global market due to the …
Continue reading “Radiopharmaceuticals Market is anticipated to US$ 9.5 Billion by 2022 to 2032”
Radiopharmaceuticals Market is anticipated to flourish at a value CAGR of 4.3% by forecast 2022 to 2032
As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market would be valued US$ 6.2 billion in 2022. The market for radiopharmaceuticals is expected to grow at a value CAGR of 4.3% between 2022 and 2032, reaching US$ 9.5 billion. North America will account for more than 47% …
Radiopharmaceuticals Market is anticipated to flourish at a value CAGR of 4.3% to reach US$ 9.5 Billion
As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market is expected to be worth US$ 6.2 billion in 2022, according to Future Market Insights (FMI). During the forecast period of 2022 to 2032, radiopharmaceutical uptake is expected to grow at a 4.3% CAGR to reach US$ 9.5 billion. North …